Linkedin
Facebook
Twitter
Youtube

23 Feb CEVEC

Posted at 18:59h in by

Nicole Faust, Ph.D., CEO

April 13 | 4:15pm | Dark Horse Consulting Ballroom 

Cologne, Germany

(Private)

In-Person Presentation

CEVEC – now part of Cytiva- is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises various platform technologies for gene therapy vectors, vector vaccines and complex recombinant proteins. In the viral vector space, ELEVECTA® is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors, the CAP® Ad Technology is the perfect fit. 

www.cevec.com



About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 9-11, 2024
Rome Cavalieri
Via Alberto Cadlolo 101
Rome, Italy

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions